Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Lachmann

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Arthritis Research & Therapy|April 12, 2006
The in vivo expression of actin/salt-resistant hyperactive DNase I inhibits the development of anti-ssDNA and anti-histone autoantibodies in a murine model of systemic lupus erythematosusAnthony P Manderson, Francesco Carlucci, Peter J Lachmann, et al.
Human Gene Therapy|July 9, 2021
Adeno-Associated Virus Vector Gene Delivery Elevates Factor I Levels and Downregulates the Complement Alternative Pathway <i>In Vivo</i>Amina Ahmad, Mawj Mandwie, Anna K Dreismann, et al.
Human Gene Therapy|March 16, 2022
Conversion of the Liver into a Biofactory for DNaseI Using Adeno-Associated Virus Vector Gene Transfer Reduces Neutrophil Extracellular Traps in a Model of Systemic Lupus ErythematosusAmina Ahmad, Mawj Mandwie, Kim M O'Sullivan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 12, 2017
Lectin pathway effector enzyme mannan-binding lectin-associated serine protease-2 can activate native complement C3 in absence of C4 and/or C2Sadam Yaseen, Gregory Demopulos, Thomas Dudler, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2014
Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infectionYoussif Mohammed Ali, Azam Hayat, Bayad Mawlood Saeed, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Arthritis Research & Therapy|April 12, 2006
The in vivo expression of actin/salt-resistant hyperactive DNase I inhibits the development of anti-ssDNA and anti-histone autoantibodies in a murine model of systemic lupus erythematosusAnthony P Manderson, Francesco Carlucci, Peter J Lachmann, et al.
Human Gene Therapy|July 9, 2021
Adeno-Associated Virus Vector Gene Delivery Elevates Factor I Levels and Downregulates the Complement Alternative Pathway <i>In Vivo</i>Amina Ahmad, Mawj Mandwie, Anna K Dreismann, et al.
Human Gene Therapy|March 16, 2022
Conversion of the Liver into a Biofactory for DNaseI Using Adeno-Associated Virus Vector Gene Transfer Reduces Neutrophil Extracellular Traps in a Model of Systemic Lupus ErythematosusAmina Ahmad, Mawj Mandwie, Kim M O'Sullivan, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 12, 2017
Lectin pathway effector enzyme mannan-binding lectin-associated serine protease-2 can activate native complement C3 in absence of C4 and/or C2Sadam Yaseen, Gregory Demopulos, Thomas Dudler, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2014
Low-dose recombinant properdin provides substantial protection against Streptococcus pneumoniae and Neisseria meningitidis infectionYoussif Mohammed Ali, Azam Hayat, Bayad Mawlood Saeed, et al.
Pageof 3